Article Details

LineaRx's iCTC Platform for Isolation of Circulating Tumor Cells Shows Superior Correlation over ...

Retrieved on: 2019-09-30 20:22:30

Tags for this article:

Click the tags to see associated articles and topics

LineaRx's iCTC Platform for Isolation of Circulating Tumor Cells Shows Superior Correlation over .... View article details on hiswai:

Excerpt

<div>STONY BROOK, N.Y.--(BUSINESS WIRE)--LineaRx, Inc., the majority-owned subsidiary of <b>Applied DNA Sciences</b>, Inc. (NASDAQ: APDN) focused on ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up